146 related articles for article (PubMed ID: 18333374)
1. Integrin expression on monocytes and lymphocytes in unstable angina short term effects of atorvastatin.
Dobreanu M; Dobreanu D; Fodor A; Bacarea A
Rom J Intern Med; 2007; 45(2):193-9. PubMed ID: 18333374
[TBL] [Abstract][Full Text] [Related]
2. Effects of Atorvastatin on some inflammatory parameters in severe primary hypercholesterolemia.
Dobreanu M; Gălăţeanu C; Simionescu A; Deac R
Rom J Intern Med; 2002; 40(1-4):61-73. PubMed ID: 15526541
[TBL] [Abstract][Full Text] [Related]
3. Serum profiles of matrix metalloproteinases and their tissue inhibitor in patients with acute coronary syndromes. The effects of short-term atorvastatin administration.
Tziakas DN; Chalikias GK; Parissis JT; Hatzinikolaou EI; Papadopoulos ED; Tripsiannis GA; Papadopoulou EG; Tentes IK; Karas SM; Chatseras DI
Int J Cardiol; 2004 Apr; 94(2-3):269-77. PubMed ID: 15093992
[TBL] [Abstract][Full Text] [Related]
4. The impact of early administration of low-dose atorvastatin treatment on inflammatory process, in patients with unstable angina and low cholesterol level.
Tousoulis D; Antoniades C; Katsi V; Bosinakou E; Kotsopoulou M; Tsioufis C; Stefanadis C
Int J Cardiol; 2006 Apr; 109(1):48-52. PubMed ID: 16002160
[TBL] [Abstract][Full Text] [Related]
5. Effects of early administration of atorvastatin treatment on thrombotic process in normocholesterolemic patients with unstable angina.
Tousoulis D; Bosinakou E; Kotsopoulou M; Antoniades C; Katsi V; Stefanadis C
Int J Cardiol; 2006 Jan; 106(3):333-7. PubMed ID: 16337041
[TBL] [Abstract][Full Text] [Related]
6. Clinical and angiographic correlates of leukocyte activation in unstable angina.
De Servi S; Mazzone A; Ricevuti G; Mazzucchelli I; Fossati G; Gritti D; Angoli L; Specchia G
J Am Coll Cardiol; 1995 Nov; 26(5):1146-50. PubMed ID: 7594025
[TBL] [Abstract][Full Text] [Related]
7. Gender differences in short-term effects of atorvastatin on lipid profile, fibrinolytic parameters, and endothelial function.
Sakabe K; Fukuda N; Fukuda Y; Wakayama K; Nada T; Morishita S; Shinohara H; Tamura Y
Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):182-8. PubMed ID: 17399968
[TBL] [Abstract][Full Text] [Related]
8. Effect of atorvastatin on circulating proinflammatory T-lymphocyte subsets and soluble CD40 ligand in patients with stable coronary artery disease--a randomized, placebo-controlled study.
Alber HF; Frick M; Suessenbacher A; Doerler J; Schirmer M; Stocker EM; Dichtl W; Pachinger O; Weidinger F
Am Heart J; 2006 Jan; 151(1):139. PubMed ID: 16368305
[TBL] [Abstract][Full Text] [Related]
9. Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response.
Arazi SS; Genvigir FD; Willrich MA; Hirata MH; Dorea EL; Bernik M; Hirata RD
Clin Chim Acta; 2008 Jul; 393(2):119-24. PubMed ID: 18435918
[TBL] [Abstract][Full Text] [Related]
10. The effects of atorvastatin on gluten-induced intestinal T cell responses in coeliac disease.
Ráki M; Molberg O; Tollefsen S; Lundin KE; Sollid LM
Clin Exp Immunol; 2005 Nov; 142(2):333-40. PubMed ID: 16232221
[TBL] [Abstract][Full Text] [Related]
11. (TTA)n polymorphism in 3-hydroxy-3-methylglutaryl-coenzyme A and response to atorvastatin in coronary artery disease patients.
Noriega V; Pennanen C; Sánchez MP; Chiong M; Llancaqueo M; Lavandero S; Prieto JC
Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):211-5. PubMed ID: 19067673
[TBL] [Abstract][Full Text] [Related]
12. Effects of atorvastatin on C-reactive protein secretions by adipocytes in hypercholesterolemic rabbits.
Zhang D; Che D; Zhao S; Sun Y
J Cardiovasc Pharmacol; 2007 Sep; 50(3):281-5. PubMed ID: 17878756
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin reduces fibrinogen levels in patients with severe hypercholesterolemia: additional evidence to support the anti-inflammatory effects of statins.
Leibovitz E; Hazanov N; Frieman A; Elly I; Gavish D
Isr Med Assoc J; 2004 Aug; 6(8):456-9. PubMed ID: 15326822
[TBL] [Abstract][Full Text] [Related]
14. Effects of atorvastatin on red-blood cell Na(+)/Li(+) countertransport in hyperlipidemic patients with and without hypertension.
Kosmidou MS; Hatzitolios AI; Adamidou A; Giannopoulos S; Raikos N; Parharidis G; Milionis HJ
Am J Hypertens; 2008 Mar; 21(3):303-9. PubMed ID: 18202666
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of atorvastatin during early hospitalization in elderly patients with unstable angina.
Zhao Z; Geng J; Ge ZM; Wang W; Zhang Y; Kang WQ
Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):554-8. PubMed ID: 19673939
[TBL] [Abstract][Full Text] [Related]
16. Effects of statin treatment in men and women with stable coronary heart disease: a subgroup analysis of the GREACE Study.
Athyros VG; Kakafika AI; Papageorgiou AA; Paraskevas KI; Tziomalos K; Anagnostis P; Pagourelias E; Koumaras C; Karagiannis A; Mikhailidis DP
Curr Med Res Opin; 2008 Jun; 24(6):1593-9. PubMed ID: 18430270
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of the immune system in primary hypercholesterolaemia: effect of atorvastatin therapy.
Sampietro T; Bigazzi F; Rossi G; Dal Pino B; Puntoni MR; Sbrana F; Chella E; Bionda A
J Intern Med; 2005 Jun; 257(6):523-30. PubMed ID: 15910556
[TBL] [Abstract][Full Text] [Related]
18. Effects of atorvastatin and pravastatin on glucose tolerance, adipokine levels and inflammatory markers in hypercholesterolaemic patients.
Ando H; Sugimoto K; Yanagihara H; Tsuruoka S; Saito T; Takamura T; Kaneko S; Fujimura A
Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1012-7. PubMed ID: 18430053
[TBL] [Abstract][Full Text] [Related]
19. Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysis.
Giraldez RR; Giugliano RP; Mohanavelu S; Murphy SA; McCabe CH; Cannon CP; Braunwald E
J Am Coll Cardiol; 2008 Sep; 52(11):914-20. PubMed ID: 18772061
[TBL] [Abstract][Full Text] [Related]
20. HMG-CoA reductase inhibitors deplete circulating classical and non-classical monocytes following human heart transplantation.
Fildes JE; Shaw SM; Mitsidou A; Rogacev K; Leonard CT; Williams SG; Yonan N
Transpl Immunol; 2008 May; 19(2):152-7. PubMed ID: 18503891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
